| Date Filed | Type | Description |
| 10/03/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 1,384 shares
@ $27.0775, valued at
$37.5k
|
|
| 08/23/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 853 shares
@ $829, valued at
$707.1k
Exercised 853 options to buy
@ $391.92, valued at
$334.3k
|
|
| 08/11/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 853 shares
@ $789, valued at
$673k
Exercised 853 options to buy
@ $391.92, valued at
$334.3k
|
|
| 06/30/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 1,208 shares
@ $31.0273, valued at
$37.5k
|
|
| 03/31/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 1,049 shares
@ $35.7276, valued at
$37.5k
|
|
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,021 shares
@ $779, valued at
$795.4k
Exercised 1,021 options to buy
@ $380.95, valued at
$388.9k
|
|
| 01/05/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 165 shares
@ $0
Granted 1,929 options to buy
@ $725.89, valued at
$1.4M
|
|
| 01/03/2023 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 943 shares
@ $39.7613, valued at
$37.5k
|
|
| 12/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/12/2022 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,279 shares
@ $705, valued at
$901.7k
Sold 1,279 shares
@ $686.99, valued at
$878.7k
Sold 609 shares
@ $741, valued at
$451.3k
Exercised 609 options to buy
@ $376.69, valued at
$229.4k
Exercised 1,279 options to buy
@ $391.92, valued at
$501.3k
|
|
| 06/30/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/11/2022 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,240 shares
@ $725, valued at
$899k
Exercised 1,240 options to buy
@ $380.95, valued at
$472.4k
|
|
| 04/01/2022 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 964 shares
@ $38.8703, valued at
$37.5k
|
|
| 04/01/2022 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 1,240 shares
@ $700, valued at
$868k
Exercised 1,240 options to buy
@ $380.95, valued at
$472.4k
|
|
| 01/05/2022 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Granted 191 shares
@ $0
Granted 2,707 options to buy
@ $625.6, valued at
$1.7M
|
|
| 01/03/2022 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 958 shares
@ $39.1051, valued at
$37.5k
|
|
| 09/30/2021 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 992 shares
@ $37.8016, valued at
$37.5k
|
|
| 08/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2021 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on REGENERON PHARMACEUTICALS, INC.|
Txns:
| Sold 2,559 shares
@ $600, valued at
$1.5M
Exercised 2,559 options to buy
@ $391.92, valued at
$1M
|
|
| 07/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2021 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Granted 15,000 options to buy
@ $7.44, valued at
$111.6k
|
|
| 06/30/2021 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Royalty Pharma plc|
Txns:
| Granted 871 shares
@ $43.0416, valued at
$37.5k
|
|
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/25/2021 |
4
| Bassler Bonnie L (Director) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $2.51, valued at
$87.9k
|
|
| 01/25/2021 |
3
| Bassler Bonnie L (Director) has filed a Form 3 on Cidara Therapeutics, Inc. |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|